Health
Clinical Challenges: When to Add Immunotherapy in Breast Cancer – MedPage Today
Immune checkpoint inhibitors and other immunotherapies may soon have an expanded role
For breast cancer patients, the current indications for immune checkpoint inhibitors (ICIs) are generally limited to triple-negative breast cancer (TNBC), both in high-risk early-stage disease or in the advanced setting for tumors with certain levels of…
Continue Reading
-
General22 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
General19 hours agoHome of Andrii Yermak, Zelenskyy’s chief of staff, raided by anti-corruption unit
-
General23 hours agoOne of seven Rosenberg’s goannas from ACT reserve is missing from home for second time in two years
-
General8 hours agoProtecting victims of explicit AI content online